-
Views
-
Cite
Cite
Chunhong Liang, Yuyang Zhou, Ying Li, Mei Xu, Changping Li, Follow-up and Analysis of Helicobacter pylori Antibioic Resistance in the South Area of Sichuan Province, The Journal of Infectious Diseases, Volume 232, Issue Supplement_4, 15 November 2025, Pages S418–S424, https://doi.org/10.1093/infdis/jiaf402
Close - Share Icon Share
Abstract
Background
The antibiotic resistance rate of Helicobacter pylori (H. pylori) has increased year by year with the widespread use of antibiotics, resulting in reduced efficacy of eradication therapy and increased recurrence rate. We conducted a survey on H. pylori resistance in the South area of Sichuan province to provide guidance for front-line treatments of H. pylori in this area.
Methods
Helicobacter pylori strains were isolated from gastric mucosa specimens obtained from patients with suspected H. pylori infection from the South area of Sichuan province. Antibiotic susceptibility of the strains was determined by disk diffusion method.
Results
Among 373 patients, 323 were from southern Sichuan. H. pylori strains were isolated and cultured from gastric mucosa samples of 304 patients, resulting in an isolation and culture success rate of 81.50%. Metronidazole (MNZ) is the antibiotic with the highest drug resistance rate in the South area of Sichuan province, with a drug resistance rate as high as 98.68%. The resistance rates of amoxicillin and furazolidone were very low, accounting for 0.29% and 0.99%, respectively. However, tetracycline showed no resistance. Single antibiotic resistance accounted for 35.67%, while the resistance to 2 antibiotics was dual resistance, accounting for 34.67%. Dual drug resistance was mainly MNZ and levofloxacin, followed by MNZ and clarithromycin (CLA).
Conclusions
MNZ, levofloxacin, and CLA should be used cautiously in H. pylori eradication therapy in the South area of Sichuan province. If the cultivation results and drug sensitivity test results of the H. pylori strain cannot be obtained, it is recommended to adopt an empirical treatment plan, using the pairwise combinations of amoxicillin, tetracycline, and FZD, especially the combination of amoxicillin and tetracycline.